Chromatographia

, Volume 59, Supplement 1, pp S61–S67 | Cite as

Quantitative Determination of Carisoprodol and its Metabolites in Equine Urine and Serum by Liquid Chromatography-Tandem Mass Spectrometry

Article

Abstract

A liquid chromatography-tandem mass spectrometry (LC-MS-MS) method was developed for the quantitation of carisoprodol and its metabolites, meprobamate and hydroxycarisoprodol, in equine urine and serum. The method consists of solid phase extraction followed by LC-MS-MS using electrospray ionization (ESI) and multiple reaction monitoring. Validation of the method showed excellent sensitivity, selectivity, accuracy, precision and ruggedness. The urinary excretion and serum profiles of these analytes were determined after oral administration of carisoprodol and meprobamate. The determination of hydroxycarisoprodol in urine and/or intact carisprodol in serum allows one to effectively distinguish between specimens arising from administration of carisoprodol (a class 4 drug violation) and meprobamate (a class 2 violation).

Keywords

Column liquid chromatography-mass spectrometry Urinary elimination Carisoprodol Meprobamate 

References

  1. Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM (1999) J Addict Diseas 18:51–56Google Scholar
  2. Bailey DN, Briggs JR (2002) Am J Clin Pathol 117:396–400PubMedGoogle Scholar
  3. Gillard Y, Bilault F, Pepin G (1997) Forensic Sci Internat 86:173–180CrossRefGoogle Scholar
  4. Kintz P, Mangin P (1993) J Anal Toxicol 17:408–410PubMedGoogle Scholar
  5. The Association of Racing Commisioners International, Inc. (2002) Uniform classification guidelines for foreign substances and recommended penalties and model ruleGoogle Scholar
  6. The Association of Official Racing Chemists (2002) Minimum performance criteria for chromatography and mass spectrometry, AORC Internal CommunicationGoogle Scholar
  7. Draft Guidance for Industry, Mass Spectrometry for Confirmation of the Identity of Animal Drug Residues (June 6, 2002) United States FDA Center for Veterinary MedicineGoogle Scholar
  8. Bressolle F, Bromet-Petit M, Audran M (1996) J Chrom B Biomed Applic 686:3–10CrossRefGoogle Scholar
  9. Olsen H, Koppang E, Alvan G, Morland J (1994) Ther Drug Monit 16:337–40PubMedGoogle Scholar
  10. Bossoni G, Colasanti P, Bianchi S, Riva M, Usardi MM (1979) Pharmacol Res Commun 11:693–702PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg&Sohn Verlagsgesellschaft mbH 2004

Authors and Affiliations

  1. 1.Equine Analytical Chemistry LaboratoryCalifornia Animal Health and Food SafetyUSA

Personalised recommendations